GOT DX?Redefining ICD Therapy - Clinical Advantages of DX as the High Voltage Therapy of Choice скачать в хорошем качестве

GOT DX?Redefining ICD Therapy - Clinical Advantages of DX as the High Voltage Therapy of Choice

Recorded on December 18th, 2025 Clinical Insights with Dr. Luigi Di Biase Dr. Luigi Di Biase will share his firsthand experience treating and managing patients using the DX platform as his primary high-voltage therapy of choice within the Montefiore Health System. Dr. Di Biase will highlight the key advantages of this approach, including: • AHRE detection • OAC management • SVT discrimination • Longevity • Realizing the clinical value of applying dual chamber insights while using less hardware. He will also share his views on appropriate patient selection for DX versus Extravascular and Dual-Chamber ICDs, and will showcase several of his own DX case studies. Don’t miss this opportunity to gain advanced clinical understanding and perspective on BIOTRONIK’s unique DX technology with Dr. Luigi Di Biase. Luigi Di Biase, M.D., Ph.D. System Director of Electrophysiology at Montefiore Health Systems Professor of Medicine Cardiology at Albert Einstein College of Medicine Director of Arrhythmia Services, Department of Medicine Dr. Luigi Di Biase, MD, PhD, FACC, FHRS, is System Director of Electrophysiology at Montefiore Health system, Section Head of Electrophysiology, Director of Arrhythmia Services, and Professor of Medicine (Cardiology) at Einstein/Montefiore. In addition, he serves as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas. Improving patient care is the heart of Dr. Di Biase's mission. He believes that this is possible through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.